View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Sept. 25 (HealthDay News) -- In obese patients, bariatric surgery can aid in achieving sustainable remission and improvement of type 2 diabetes mellitus (T2DM), according to a study published in the October issue of the Annals of Surgery.
Stacy A. Brethauer, M.D., from the Cleveland Clinic, and colleagues assessed clinical outcomes in patients with T2DM who underwent bariatric surgery between 2004 and 2007 and were followed for a median of six years. Glycated hemoglobin (A1C) <6 percent and fasting blood glucose (FBG) <100 mg/dL while off diabetes medications defined complete remission.
The researchers found that a mean excess weight loss (EWL) of 55 percent was associated with significant mean reductions in A1C and FBG. Compared to baseline, over one-third of patients (34 percent) had improved A1C (>1 percent decrease without remission) and 16 percent remained unchanged, while long-term complete and partial remission rates were 24 and 26 percent, respectively. Remission was significantly predicted by shorter duration of T2DM and higher long-term EWL. After initial remission, recurrence of T2DM occurred in 19 percent and was significantly associated with longer duration of T2DM, less EWL, and weight regain.
"Surgical intervention within five years of diagnosis is associated with a high rate of long-term remission," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top